Best Peptides for Sleep: Full Stack and Doses 2026
DSIP, Tesamorelin, and GHK-Cu are the peptides most often grouped in sleep and overnight-recovery discussions. This is an educational comparison of what they are and why they get mentioned together, not a stack to run.
Educational comparison, not a protocol. This page describes which compounds are discussed together for sleep and the mechanism rationale behind that grouping. It contains no doses, frequencies, timing, or cycle structures. DSIP and injectable GHK-Cu are research-grade with no established human dosing; any specifics belong with a licensed clinician.
The Three Compounds, and Why They Are Grouped
DSIP, Sleep Induction
Delta Sleep Inducing Peptide, a 9-amino-acid peptide researched for promoting slow-wave (delta) sleep, the deepest and most restorative stage.
Studied for: Sleep onset, deep sleep duration
Studied route: Subcutaneous (research)
Tesamorelin, GH Pulse
A GHRH analogue that triggers a natural growth hormone pulse from the pituitary. The natural GH peak overlaps with deep sleep, which is why it appears in sleep-recovery discussions.
Studied for: GH pulse, body composition
Studied route: Subcutaneous
GHK-Cu, Overnight Repair
Copper tripeptide studied for cytokine modulation, antioxidant pathways, and connective tissue regeneration, the repair angle of the overnight-recovery conversation.
Studied for: Tissue repair, recovery
Studied route: Subcutaneous
The complementary rationale: DSIP is associated with getting into deep sleep, Tesamorelin with the GH pulse that overlaps that window, and GHK-Cu with the repair that happens during it. Three angles on one overnight process is why the names appear together. It is a description of mechanism, not an endorsement of stacking them.
What the Research Does and Does Not Establish
The mechanisms are plausible, but the human evidence for a sleep protocol is not established. DSIP research is limited, injectable GHK-Cu for sleep is research-grade, and Tesamorelin is approved for an unrelated indication rather than as a sleep aid. Community dosing and timing claims are not a substitute for that gap.
The best-supported sleep inputs, schedule consistency, light and caffeine management, and addressing underlying causes, are also the least controversial, and they are where most durable improvement actually comes from.
Common Questions
Q: Why are DSIP, Tesamorelin, and GHK-Cu discussed together for sleep?
A: They map to three layers of overnight recovery: DSIP to deep-sleep induction, Tesamorelin to the growth hormone pulse that overlaps with deep sleep, and GHK-Cu to tissue repair. People group them because those mechanisms are complementary, which is an explanation of the rationale, not a recommendation to combine them.
Q: Does this page give a sleep stack with doses or timing?
A: No. It contains no doses, frequencies, timing, or cycle structures, despite what the title targets. Those are clinical decisions. Of the three, only Tesamorelin has an approved label, and even there the specifics belong with a prescriber.
Q: What actually helps sleep that is well supported?
A: Sleep hygiene, a consistent schedule, managing caffeine and evening screens, and treating underlying issues are the best-supported levers for sleep. They sit outside the peptide conversation and are where most real improvement comes from.
Q: Are these approved sleep treatments?
A: DSIP and injectable GHK-Cu are research-grade with no established human dosing for sleep. Tesamorelin is approved for a different, specific medical indication, not as a sleep aid. None of this establishes a self-administered sleep protocol.
Glucose & cancer caution: Tesamorelin raises IGF-1 through GH release, which is relevant for anyone with diabetes, active cancer, or a cancer history. Copper peptides also carry considerations for copper-related conditions. These are reasons suitability is individual and best evaluated with a qualified physician.
Important Disclaimer
Educational content only. Not medical advice, and not a protocol. This page provides no dosing, schedule, or timing guidance. Except where an approved label applies to a separate indication, the compounds discussed are not approved by Vietnam's Ministry of Health (Bộ Y Tế) or the Drug Administration of Vietnam (DAV) for the uses described. Consult a licensed physician before considering any use.